Novartis (NYSE: NVS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Novartis (NYSE: NVS) through any online brokerage.
The latest price target for Novartis (NYSE: NVS) was reported by Wolfe Research on Monday, May 9, 2022. The analyst firm set a price target for 0.00 expecting NVS to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Novartis (NYSE: NVS) is $83.725 last updated July 6, 2022, 7:59 PM UTC.
A quarterly cash dividend of $2.18 per share of Class A Common Stock. The quarterly cash dividend was payable on March 17, 2022 to stockholders of record on March 8, 2022.
Novartis’s Q2 earnings are confirmed for Tuesday, July 19, 2022.
There is no upcoming split for Novartis.
Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.